Skip to main content
background gradient

Volume 14Issue 4

Industry Update

Open Access
R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 18
  • Paul Arora and
  • Sreeram V Ramagopalan
e250014
Published Online:18 February 2025
Preview Abstract

Plain Language Summary of Publication

Open Access
Eculizumab or ravulizumab treatment effect in people with neuromyelitis optica spectrum disorder: a plain language summary of three studies
  • Alfredo Damasceno and
  • Mariano Marrodan
e240177
Published Online:12 February 2025
Preview Abstract

Short Report

Open Access
Trends in adoption of knotless tissue control devices in robotic surgery
  • Barbara H Johnson,
  • Sinchana T,
  • Stephen S Johnston, and
  • Najmuddin Gunja
e240229
Published Online:17 March 2025
Preview Abstract

Research Article

Open Access
Matching-adjusted indirect comparisons of efficacy outcomes between etrasimod and ozanimod for moderately to severely active ulcerative colitis
  • Vipul Jairath,
  • Tim Raine,
  • Thomas P Leahy,
  • Ravi Potluri,
  • Karolina Wosik,
  • David Gruben,
  • Joseph C Cappelleri,
  • Peter Hur, and
  • Lauren Bartolome
e240193
Published Online:24 February 2025
Preview Abstract
Open Access
Comparison of real-world healthcare resource utilization and costs among patients with hereditary angioedema on lanadelumab or berotralstat long-term prophylaxis
  • Nicole Princic,
  • Kristin A Evans,
  • Chintal H Shah,
  • Krystal Sing,
  • Salomé Juethner, and
  • Bob G Schultz
e240205
Published Online:20 February 2025
Preview Abstract
Open Access
Burden of illness for patients with primary biliary cholangitis: an observational study of clinical characteristics and healthcare resource utilization
  • Robert G Gish,
  • Joanna P MacEwan,
  • Alina Levine,
  • Dannielle Lebovitch,
  • Leona Bessonova,
  • Darren Wheeler,
  • Radhika Nair, and
  • Alan Bonder
e240174
Published Online:6 March 2025
Preview Abstract

Systematic Review

Open Access
The role of health economic evidence in clinical practice guidelines for colorectal cancer: a comparative analysis across countries
  • Xiaoyu Yan,
  • Yue Wang,
  • Aixia Ma, and
  • Hongchao Li
e240226
Published Online:19 February 2025
Preview Abstract

Review

Open Access
Evaluation of reporting in time-driven activity-based costing studies on cardiovascular diseases: a scoping review
  • Nayê Balzan Schneider,
  • Erica Caetano Roos,
  • Miriam Allein Zago Marcolino,
  • Fabio Caldana,
  • Filipe Rodrigues Vargas do Nascimento,
  • Sérgio Renato da Rosa Decker,
  • Ana Paula Beck da Silva Etges, and
  • Carisi Anne Polanczyk
e240013
Published Online:26 February 2025
Preview Abstract

Perspective

Open Access
Real-world evidence: state-of-the-art and future perspectives
  • Heather Fitzke,
  • Tamanah Fayzan,
  • Jonathan Watkins,
  • Evgeny Galimov, and
  • Benjamin F Pierce
e240130
Published Online:7 March 2025
Preview Abstract